AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
63 hedge funds and large institutions have $19.3M invested in Asterias Biotherapeutics Inc. Series A in 2015 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $144K
Holders
63
Holding in Top 10
1
Calls
–
Puts
$144K
Top Buyers
| 1 | +$4.6M | |
| 2 | +$1.27M | |
| 3 | +$830K | |
| 4 |
Millennium Management
New York
|
+$362K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$293K |
Top Sellers
| 1 | -$425K | |
| 2 | -$312K | |
| 3 | -$124K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$111K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$76.6K |